Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Shares Outstanding (Diluted Average) (2022 - 2025)

Dna X filings provide 4 years of Shares Outstanding (Diluted Average) readings, the most recent being $722689.0 for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 175.71% to $722689.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $722689.0, a 175.71% increase, with the full-year FY2025 number at $722689.0, up 175.71% from a year prior.
  • Shares Outstanding (Diluted Average) hit $722689.0 in Q4 2025 for Dna X, down from $984927.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $41.1 million in Q1 2023 to a low of $262118.0 in Q4 2024.
  • Median Shares Outstanding (Diluted Average) over the past 4 years was $4.5 million (2023), compared with a mean of $11.5 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): tumbled 93.89% in 2024 and later surged 265.62% in 2025.
  • Dna X's Shares Outstanding (Diluted Average) stood at $28.9 million in 2022, then tumbled by 85.16% to $4.3 million in 2023, then tumbled by 93.89% to $262118.0 in 2024, then skyrocketed by 175.71% to $722689.0 in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $722689.0 (Q4 2025), $984927.0 (Q3 2025), and $9.5 million (Q2 2025) per Business Quant data.